Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose acetylsalicylic acid to prevent preeclampsia after frozen embryo transfer
2024-516816-72-00Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Cartia in preeclampsia (2 arms), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Incidence of preeclampsia. Started Sep 2024; status: completed.
02
Drugs
Cartia
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2024-516816-72-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516816-72-00.